These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33627143)

  • 1. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance.
    Wang H; Li R; Zhou Z; Jiang H; Yan Z; Tao X; Li H; Xu L
    J Cardiovasc Magn Reson; 2021 Feb; 23(1):14. PubMed ID: 33627143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation of Myocardial Involvement in Patients Recovered From COVID-19 by Using Cardiac Magnetic Resonance Imaging, In a Tertiary Care Hospital, Bangladesh.
    Ghafoor N; Islam MM; Shakil SN; Deepa KP; Dutta AK; Medha KA; Siddiqui M; Siraj N; Parven JA; Showkat MS
    Mymensingh Med J; 2022 Oct; 31(4):1108-1114. PubMed ID: 36189559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).
    Puntmann VO; Carerj ML; Wieters I; Fahim M; Arendt C; Hoffmann J; Shchendrygina A; Escher F; Vasa-Nicotera M; Zeiher AM; Vehreschild M; Nagel E
    JAMA Cardiol; 2020 Nov; 5(11):1265-1273. PubMed ID: 32730619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study.
    Galea N; Marchitelli L; Pambianchi G; Catapano F; Cundari G; Birtolo LI; Maestrini V; Mancone M; Fedele F; Catalano C; Francone M
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):68. PubMed ID: 34107985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cardiovascular magnetic resonance imaging in COVID-19 recovered patients: A short-term follow-up study.
    Kunal S; Bagarhatta P; Palleda GM; Bansal A; Batra V; Daga MK; Tyagi S; Sharma A; Bansal K; Agarwal R; Gupta MD
    Echocardiography; 2022 Nov; 39(11):1401-1411. PubMed ID: 36266740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement.
    Urmeneta Ulloa J; Martínez de Vega V; Salvador Montañés O; Álvarez Vázquez A; Sánchez-Enrique C; Hernández Jiménez S; Sancho García FD; López Ruiz L; Recio Rodríguez M; Pizarro G; Carnevali Ruiz D; Ángel Cabrera J
    Int J Cardiol Heart Vasc; 2021 Oct; 36():100854. PubMed ID: 34368419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
    Steen H; Giusca S; Montenbruck M; Patel AR; Pieske B; Florian A; Erley J; Kelle S; Korosoglou G
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):45. PubMed ID: 33823860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis.
    Hadley SM; Prakash A; Baker AL; de Ferranti SD; Newburger JW; Friedman KG; Dionne A
    Eur J Pediatr; 2022 Jul; 181(7):2879-2883. PubMed ID: 35482094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children.
    Sirico D; Basso A; Sabatino J; Reffo E; Cavaliere A; Biffanti R; Cerutti A; Castaldi B; Zulian F; Da Dalt L; Di Salvo G
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1066-1074. PubMed ID: 35639926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy.
    Xu Y; Sun J; Wan K; Yu L; Wang J; Li W; Yang F; Sun J; Cheng W; Mui D; Zhang Q; Xie Q; Chen Y
    J Cardiovasc Magn Reson; 2020 Apr; 22(1):22. PubMed ID: 32272936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis.
    Feher A; Miller EJ; Peters DC; Mojibian HR; Sinusas AJ; Hinchcliff M; Baldassarre LA
    Rheumatol Int; 2023 May; 43(5):849-858. PubMed ID: 36894756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.